Citations 1
Phase 3 study of oral lenalidomide as maintenance therapy for patients with B-cell chronic lymphocytic leukemia (CLL).
Chanan‐Khan, Asher , Zaritskey, Andrey , Egyed, Miklós , Samoylova, Olga, Simpson, David , Mei, Jay , Oliveira, Natália , Kong, O, Foà, Robin , Vokurka, Samuel , Schuh, Anna
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS7125-TPS7125
